Redox Effects of Selenium for Prostate Cancer Prevention
Redox Effects of Selenium for Prostate Cancer Prevention
批准号:
7226232
负责人:
WEIXIONG ZHONG
金额:
$27.25万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-18 至 2009-02-28
关键词:
2 year oldAgeAge-YearsAgreementAntioxidantsApoptosisApplications GrantsCell Cycle ArrestCell LineCellsChemicalsChemopreventionChemopreventive AgentClinical TrialsComplementary DNADataDevelopmentDietary InterventionDietary SeleniumEnzymesEpidemiologic StudiesEpithelial CellsGene TargetingGenesGlutathione DisulfideGrowthHumanIn VitroIncidenceIndividualInhibition of ApoptosisInterventionLNCaPMalignant NeoplasmsMalignant neoplasm of prostateManganese Superoxide DismutaseMeasuresMediatingMitochondriaMolecular TargetNeoplasm MetastasisOxidation-ReductionOxidative StressPC3 cell linePathway interactionsPatientsPhosphorylationPlayProductionProstateProtein OverexpressionProtein p53ProteinsRNA InterferenceRateReactive Oxygen SpeciesRecruitment ActivityReduced GlutathioneRegulationResearch PersonnelRoleSOD2 geneSeleniumSelenium and Vitamin E Efficacy TrialSerumSmall Interfering RNAStagingStructure of nail of toeSuperoxide DismutaseSuperoxidesSupplementationTP53 geneTestingTranscriptional ActivationTransfectionTumor PromotionUp-Regulationcancer cellcancer preventioncatalasecell growthconceptcopper zinc superoxide dismutasegenetic regulatory proteinglutathione peroxidaseinsightlatent prostate cancermenoxidationprogramsprostate cancer preventionresponse
中文摘要
描述(由申请人提供):最近的研究表明,硒(Se)可降低人类前列腺癌的发病率,并在体外诱导前列腺癌细胞的凋亡和生长抑制。然而,硒的潜在化学预防机制仍不清楚。硒引起的超氧自由基的产生被认为是其潜在的机制之一。我们的研究表明,硒诱导细胞凋亡和生长抑制与超氧自由基的产生和上调p53,p21(Waf 1),Bax,和一些抗氧化酶,这表明还原-氧化(氧化还原)介导的影响硒对p53的激活。因此,我们假设硒诱导前列腺癌细胞的生长抑制和凋亡,部分通过调节细胞的氧化还原状态,导致p53,Bax和p21(Waf 1)的上调和激活。具体目标1是确定硒是否有差异氧化还原作用,在正常的前列腺上皮细胞,永生化上皮细胞,和癌细胞通过测量细胞的抗氧化状态,活性氧水平,和氧化应激硒治疗后。具体目标2是确定超氧自由基的产生是否在硒对p53磷酸化和激活以及随后的细胞生长抑制和凋亡的氧化还原作用中起主要作用,以及线粒体是否是细胞凋亡的主要靶点或途径;这一目标将通过改变超氧物歧化酶(SOD)的水平来测试,使用基因转染和siRNA沉默。超氧阴离子自由基和线粒体SOD 2水平与硒的细胞效应相关。具体目标3是通过基因转染和siRNA沉默来改变p53状态并抑制Bax和p21(Waf 1)通路,以确定p53及其靶基因Bax和p21(Waf 1)在Se诱导的细胞凋亡和细胞周期阻滞中的作用。拟议的研究将提供深入了解硒在前列腺癌化学预防中的机制和分子靶点,并有助于制定预防前列腺癌的特异性和有效的饮食干预策略。
英文摘要
DESCRIPTION (provided by applicant): Recent studies demonstrated that selenium (Se) reduced prostate cancer incidence in humans and induced apoptosis and growth inhibition of prostate cancer cells in vitro. However, the underlying chemopreventive mechanism(s) of Se remains unclear. Production of superoxide radicals by Se has been considered as one of the potential mechanisms. Our studies showed that Se induced cell apoptosis and growth inhibition with superoxide radical production and up-regulation of p53, p21(Waf1), Bax, and some antioxidant enzymes, suggesting a reduction-oxidation (redox)-mediated effect of Se on the activation of p53. Thus, we hypothesize that Se induces growth inhibition and apoptosis of prostate cancer cells in part by modulating cell redox state resulting in upregulation and activation of p53, Bax, and p21(Waf1). Specific Aim 1 is to determine whether Se has differential redox effects in normal prostate epithelial cells, immortalized epithelial cells, and cancer cells by measuring cellular antioxidant status, levels of reactive oxygen species, and oxidative stress following Se treatment. Specific Aim 2 is to determine whether superoxide radical production plays a major role in redox effects of Se on p53 phosphorylation and activation and subsequent cell growth inhibition and apoptosis and whether mitochondria are the primary targets or pathways for cell apoptosis; this aim will be tested by altering levels of superoxide dismutases (SOD) using gene transfection and siRNA silencing. Levels of superoxide radical and mitochondrial SOD2 will be correlated with cellular effects of Se. Specific Aim 3 is to determine the role of p53 and its target genes Bax and p21(Waf1) in Se-induced apoptosis and cell cycle arrest using gene transfection and siRNA silencing to alter p53 status and suppress Bax and p21(Waf1) pathways. The proposed studies will provide insights into the mechanism(s) and molecular targets of Se in prostate cancer chemoprevention and help in the development of specific and effective dietary intervention strategies for prostate cancer prevention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Redox Effects of Selenium for Prostate Cancer Prevention
-
批准号:6911862
-
项目类别:
-
资助金额:$28.74万
-
财政年份:2005
-
负责人:WEIXIONG ZHONG
-
依托单位:
Redox Effects of Selenium for Prostate Cancer Prevention
-
批准号:7369882
-
项目类别:
-
资助金额:$27.25万
-
财政年份:2005
-
负责人:WEIXIONG ZHONG
-
依托单位:
Redox Effects of Selenium for Prostate Cancer Prevention
-
批准号:7054645
-
项目类别:
-
资助金额:$28.06万
-
财政年份:2005
-
负责人:WEIXIONG ZHONG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: